Company
CVRx
Barostim has been shown to safely improve symptoms of heart failure and your quality of life
Also known as CVRx, Inc.
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Minneapolis, MN, United States
- Customers
- heart failure patients
- Legal name
- CVRx, Inc.
- cvrx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Barostim is an implantable device that delivers gentle electrical pulses to the baroreceptors. This increases the signals to the brain, which reduces the stress response and improves heart failure symptoms.
Funding snapshot
- Total raised
- $155MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $50M2020-07-01
Funding rounds
- Round, 2020
- $50M2020-07-01, SEC form D sold, 21 investors
- Round, 2016
- $75.3M2016-05-31, SEC form D sold, 20 investors
- Round, 2013
- $29.6M2013-06-28, SEC form D sold, 12 investors
About the company
- Status notes
- IPO in June 2021 (NASDAQ: CVRX)
Products
- Hardware
- Barostim
- Web
- Barostim
Loading relationship preview